{
    "pmcid": "8193598",
    "qa_pairs": {
        "How do nanobodies designed to target the RBD of the spike protein neutralize the virus?": [
            "By blocking the interaction between the spike protein and ACE2, preventing viral attachment to host cells.",
            "By enhancing the binding affinity of the spike protein to ACE2, increasing viral entry.",
            "By facilitating the proteolytic cleavage of the spike protein, aiding in viral activation.",
            "By destabilizing the spike protein, leading to its degradation."
        ],
        "What advantage does inhalation delivery offer for nanobody-based therapies against SARS-CoV-2?": [
            "It provides direct access to the respiratory tract, the primary site of infection.",
            "It enhances the systemic distribution of nanobodies throughout the body.",
            "It increases the half-life of nanobodies in the bloodstream.",
            "It reduces the potential for immune system recognition and clearance."
        ],
        "What is the primary role of the S1 subunit in the SARS-CoV-2 spike protein?": [
            "The S1 subunit contains the receptor-binding domain (RBD) responsible for binding to the host cell receptor ACE2.",
            "The S1 subunit facilitates membrane fusion during viral entry.",
            "The S1 subunit is involved in proteolytic cleavage for activation.",
            "The S1 subunit stabilizes the spike protein in a specific conformation."
        ],
        "What is the significance of the conformational change from 'down' to 'up' state in the spike protein?": [
            "It exposes the RBD for interaction with ACE2, which is crucial for viral entry.",
            "It enhances the spike protein's stability, reducing its susceptibility to neutralization.",
            "It facilitates the proteolytic cleavage necessary for membrane fusion.",
            "It allows the spike protein to evade immune detection by host cells."
        ],
        "Why is targeting conserved regions of the spike protein important in nanobody design?": [
            "To maintain efficacy across different SARS-CoV-2 variants and potentially other coronaviruses.",
            "To increase the binding affinity of nanobodies to the spike protein.",
            "To enhance the conformational flexibility of the spike protein.",
            "To facilitate the proteolytic activation of the spike protein."
        ]
    }
}